Mavenclad does not stop vaccines working for people with multiple sclerosis Published: 04 March 2021 A new analysis has found that people with multiple sclerosis (MS) who take Mavenclad (cladribine) do mount a protective antibody response to the seasonal influenza vaccine, and the varicella zoster virus (chicken pox).   In patients